
300006 · Chongqing Lummy Pharmaceutical Co., Ltd. Class A
5.27
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan6.27B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- HALO All
- Near Resistance
Key Fundamentals
EPS 3 yr Growth
96.00%
EBITDA Margin
-6.20%
Operating Cashflow
¥61m
Free Cash Flow Return
3.20%
ROIC
-7.00%
Interest Coverage
-3.40
Quick Ratio
1.90
Performance
52 weeks range
Low 4.1 - 6.86
Trade Value (12mth)
US$7,083,742.00
1 week
0%
1 month
18.09%
YTD
12.71%
1 year
16.47%
All time high
22.08
Additional Data
Shares Outstanding (Fully Diluted)
1,056m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak